Skip to main content
All lobbying filings

ATLAS CROSSING LLC

Lobbying for NOVOZYMES NORTH AMERICA INC. · Biosolutions company.

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · North Carolina · House · Senate · $50,000.00 income · posted Jul 20, 2026

Official filing document

 Bills named in this filing 2
  • HR 4794
    Dietary Supplements Access Act
  • S 3172
    A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products and f…
 Lobbying activity 2
Health Issues

Issues related to the expansion of HSA for dietary supplements. Issues related to the benefits of dietary supplements. Issues related to the Generally Recognized as Safe designation. H.R.4794/S.3172 - Dietary Supplements Access Act.

Food Industry (safety, labeling, etc.)

Issues related to allowance of dietary supplements in the WIC program. FY27 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem